Fentanyl Cit 1600mcg Oral Transmcsl

Manufacturer TEVA PHARMACEUTICALS USA Active Ingredient Fentanyl Lozenge(FEN ta nil) Pronunciation FEN-ta-nil SIT-rate
WARNING: This is an opioid drug. Opioid drugs can put you at risk for drug use disorder. These can lead to overdose and death. You will be watched closely while taking this drug.Severe breathing problems may happen with this drug. The risk is highest when you first start taking this drug or any time your dose is raised. These breathing problems can be deadly. Call your doctor right away if you have slow, shallow, or trouble breathing. Even one dose of this drug may be deadly if it is taken by someone else or by accident, especially in children. If this drug is taken by someone else or by accident, get medical help right away.Keep all drugs in a safe place. Keep all drugs out of the reach of children and pets.Severe side effects have happened when opioid drugs were used with benzodiazepines, alcohol, marijuana, other forms of cannabis, or street drugs. This includes severe drowsiness, breathing problems, and death. Benzodiazepines include drugs like alprazolam, diazepam, and lorazepam. If you have questions, talk with the doctor.Many drugs interact with this drug and can raise the chance of side effects like deadly breathing problems. Talk with your doctor and pharmacist to make sure it is safe to use this drug with all of your drugs.Get medical help right away if you feel very sleepy, very dizzy, or if you pass out. Caregivers or others need to get medical help right away if the patient does not respond, does not answer or react like normal, or will not wake up.If you are pregnant or plan to get pregnant, talk with your doctor right away about the benefits and risks of using this drug during pregnancy. Using this drug for a long time during pregnancy may lead to withdrawal in the newborn baby. Withdrawal in the newborn can be life-threatening if not treated. @ COMMON USES: It is used to manage pain.This drug is not for mild pain or pain that only lasts a short time (like headaches, toothaches, or pain after surgery).This drug is only for use by people who have been taking pain drugs (opioids) and are used to their effects. Talk with the doctor.
🏷️
Drug Class
Opioid analgesic
🧬
Pharmacologic Class
Opioid agonist
🀰
Pregnancy Category
Category C
βœ…
FDA Approved
Dec 1998
βš–οΈ
DEA Schedule
Schedule II

Overview

ℹ️

What is this medicine?

Fentanyl citrate oral transmucosal lozenge is a very strong opioid (narcotic) pain medicine used only for breakthrough cancer pain in patients who are already taking and are tolerant to other around-the-clock opioid pain medicines. It is designed to dissolve in your mouth to provide fast relief for sudden, severe pain flares.
πŸ“‹

How to Use This Medicine

Taking Your Medication Correctly

To use this medication properly, follow your doctor's instructions and read all the information provided. Place the lozenge in your mouth between your cheek and lower gum, and gently move it from side to side using the handle. Suck on the oral lozenge without chewing, breaking, or crushing it, and do not swallow it whole. After taking a dose, dispose of the handle in the trash, out of reach of children and pets. If any medication remains on the handle, rinse it with hot water before throwing it away to ensure the drug is fully dissolved.

Storing and Disposing of Your Medication

Store this medication at room temperature in a dry place, avoiding bathrooms. Keep it in a secure location where children cannot see or access it, and where others cannot easily obtain it. Consider using a locked box or area to safeguard the medication. Keep all medications away from pets. Dispose of unused or expired medications properly. Do not flush them down the toilet or pour them down the drain unless instructed to do so. If you have questions about disposing of medications, consult your pharmacist. You may also have access to drug take-back programs in your area.

Missing a Dose

If you take this medication regularly, take a missed dose as soon as you remember. However, if it is close to the time for your next dose, skip the missed dose and resume your regular schedule. Do not take two doses at the same time or take extra doses. If you take this medication as needed, do not take it more frequently than directed by your doctor.
πŸ’‘

Lifestyle & Tips

  • Do not drink alcohol or take other sedatives (like benzodiazepines, sleeping pills, or other pain medications) unless specifically instructed by your doctor, as this can cause dangerous breathing problems or severe drowsiness.
  • Do not drive or operate heavy machinery until you know how this medicine affects you, as it can cause dizziness and drowsiness.
  • Store this medicine securely and out of reach of children and pets. Accidental exposure can be fatal.
  • Do not cut, chew, or swallow the lozenge. It must be sucked slowly over 15 minutes.
  • Do not eat or drink while the lozenge is dissolving.

Dosing & Administration

πŸ‘¨β€βš•οΈ

Adult Dosing

Standard Dose: Individualized titration required. Initial dose is 200 mcg. Subsequent doses are titrated upwards in increments (e.g., 200 mcg, 400 mcg, 600 mcg, 800 mcg, 1200 mcg, 1600 mcg) until effective analgesia is achieved with tolerable side effects. Only one lozenge per breakthrough pain episode, with at least 4 hours between doses.
Dose Range: 200 - 1600 mg

Condition-Specific Dosing:

breakthroughCancerPain: For management of breakthrough cancer pain (BTCP) in opioid-tolerant patients only. Opioid-tolerant patients are those receiving at least 60 mg oral morphine/day, 25 mcg transdermal fentanyl/hour, 30 mg oral oxycodone/day, 8 mg oral hydromorphone/day, or an equianalgesic dose of another opioid for a week or longer.
πŸ‘Ά

Pediatric Dosing

Neonatal: Not established
Infant: Not established
Child: Not established
Adolescent: Not established (safety and efficacy not established in patients under 16 years of age)
βš•οΈ

Dose Adjustments

Renal Impairment:

Mild: Use with caution; monitor for increased effects.
Moderate: Use with caution; consider dose reduction and extended dosing intervals. Monitor closely for respiratory depression and sedation.
Severe: Use with caution; consider significant dose reduction and extended dosing intervals. Monitor closely for respiratory depression and sedation.
Dialysis: Fentanyl is not dialyzable. Use with extreme caution; significant dose reduction and extended intervals likely required. Monitor closely.

Hepatic Impairment:

Mild: Use with caution; monitor for increased effects.
Moderate: Use with caution; consider dose reduction and extended dosing intervals. Monitor closely for respiratory depression and sedation.
Severe: Use with caution; consider significant dose reduction and extended dosing intervals. Monitor closely for respiratory depression and sedation.

Pharmacology

πŸ”¬

Mechanism of Action

Fentanyl is a potent, synthetic opioid analgesic that acts primarily as a mu-opioid receptor agonist. Its principal therapeutic action is analgesia. Other pharmacological effects include respiratory depression, miosis, bradycardia, and physical dependence.
πŸ“Š

Pharmacokinetics

Absorption:

Bioavailability: Approximately 50% (25% buccal/oral mucosa, 25% swallowed and absorbed via GI tract with first-pass metabolism)
Tmax: 15-30 minutes (for buccal absorption), 1.5-2 hours (for swallowed portion)
FoodEffect: Not specifically studied for oral transmucosal lozenge, but generally, food does not significantly impact transmucosal absorption. Avoid eating/drinking while lozenge is dissolving.

Distribution:

Vd: Approximately 4 L/kg
ProteinBinding: 80-85% (primarily to alpha-1-acid glycoprotein)
CnssPenetration: Yes (rapid and extensive)

Elimination:

HalfLife: 3-7 hours (terminal elimination half-life after transmucosal administration)
Clearance: Approximately 0.5 L/hr/kg
ExcretionRoute: Mainly renal (75% as metabolites, <10% as unchanged drug); fecal (9% as metabolites)
Unchanged: <10% (renal)
⏱️

Pharmacodynamics

OnsetOfAction: 5-15 minutes (for transmucosal absorption)
PeakEffect: 20-40 minutes
DurationOfAction: 1-2 hours (for breakthrough pain relief, but analgesic effects can persist longer)

Safety & Warnings

⚠️

BLACK BOX WARNING

RISK OF RESPIRATORY DEPRESSION, ABUSE POTENTIAL, RISK EVALUATION AND MITIGATION STRATEGY (REMS), ACCIDENTAL EXPOSURE, CYTOCHROME P450 3A4 INTERACTION, and RISKS FROM CONCOMITANT USE WITH BENZODIAZEPINES OR OTHER CNS DEPRESSANTS.

RESPIRATORY DEPRESSION: Serious, life-threatening, or fatal respiratory depression may occur. Patients must be monitored for respiratory depression, especially during initiation or following a dose increase. Accidental exposure to fentanyl can result in fatal respiratory depression.

ABUSE POTENTIAL: Fentanyl exposes patients and other users to the risks of opioid addiction, abuse, and misuse, which can lead to overdose and death. Assess each patient’s risk prior to prescribing and monitor all patients regularly for the development of these behaviors or conditions.

REMS: Because of the risk of addiction, abuse, and misuse, and respiratory depression, fentanyl is available only through a restricted program called the TIRF REMS Program.

ACCIDENTAL EXPOSURE: Accidental exposure to fentanyl, especially in children, can result in a fatal overdose. Keep out of reach of children.

CYP3A4 INTERACTION: Concomitant use with CYP3A4 inhibitors can increase fentanyl plasma concentrations, which could increase or prolong adverse drug effects and may cause potentially fatal respiratory depression. Avoid concomitant use of fentanyl with CYP3A4 inhibitors. If concomitant use is necessary, monitor patients closely and consider dose reduction.

RISKS FROM CONCOMITANT USE WITH BENZODIAZEPINES OR OTHER CNS DEPRESSANTS: Concomitant use of opioids with benzodiazepines or other CNS depressants, including alcohol, may result in profound sedation, respiratory depression, coma, and death. Reserve concomitant prescribing for use in patients for whom alternative treatment options are inadequate. Limit dosages and durations to the minimum required. Follow patients for signs and symptoms of respiratory depression and sedation.
⚠️

Side Effects

Urgent Side Effects: Seek Medical Help Right Away

Although rare, some people may experience severe and potentially life-threatening side effects while taking this medication. If you notice any of the following symptoms, contact your doctor or seek immediate medical attention:

Signs of an allergic reaction, such as:
+ Rash
+ Hives
+ Itching
+ Red, swollen, blistered, or peeling skin (with or without fever)
+ Wheezing
+ Tightness in the chest or throat
+ Trouble breathing, swallowing, or talking
+ Unusual hoarseness
+ Swelling of the mouth, face, lips, tongue, or throat
Signs of low blood sugar, including:
+ Dizziness
+ Headache
+ Feeling sleepy or weak
+ Shaking
+ Fast heartbeat
+ Confusion
+ Hunger
+ Sweating
Severe dizziness or fainting
Confusion
Severe constipation or stomach pain, which may indicate a serious bowel problem
Breathing difficulties, such as:
+ Trouble breathing
+ Slow or shallow breathing
+ Noisy breathing
+ Sleep apnea (breathing problems during sleep)
Chest pain
Abnormal heartbeat (fast or slow)
Seizures
Depression
Trouble controlling body movements
Swelling in the arms or legs
Changes in eyesight

Serotonin Syndrome: A Rare but Serious Condition

If you take this medication with certain other drugs, you may be at risk for serotonin syndrome, a potentially life-threatening condition. Seek medical help immediately if you experience:

Agitation
Changes in balance
Confusion
Hallucinations
Fever
Abnormal heartbeat (fast or irregular)
Flushing
Muscle twitching or stiffness
Seizures
Shivering or shaking
Excessive sweating
Severe diarrhea, stomach upset, or vomiting
Severe headache

Adrenal Gland Problems: A Rare but Serious Condition

Taking an opioid medication like this one may lead to a rare but serious adrenal gland problem. Seek medical help immediately if you experience:

Extreme fatigue or weakness
Fainting
Severe dizziness
Severe stomach upset
Vomiting
Decreased appetite

Other Possible Side Effects

Like all medications, this drug can cause side effects. While many people may not experience any side effects or only minor ones, it's essential to contact your doctor or seek medical help if you notice any of the following:

Dizziness, sleepiness, tiredness, or weakness
Dry mouth
Constipation, diarrhea, stomach pain, upset stomach, vomiting, or decreased appetite
Headache
Feeling cold
Trouble sleeping
Excessive sweating
Irritation at the site of administration

Reporting Side Effects

If you have questions or concerns about side effects, contact your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
🚨

Seek Immediate Medical Attention If You Experience:

  • Slow, shallow, or difficult breathing
  • Extreme drowsiness or inability to wake up
  • Dizziness or lightheadedness when standing up
  • Confusion or disorientation
  • Pinpoint pupils
  • Severe constipation
πŸ“‹

Before Using This Medicine

Before Taking This Medication: Important Information to Share with Your Doctor

It is essential to inform your doctor about the following:

Any allergies you have, including allergies to this medication, its components, or other substances, such as foods or drugs. Describe the allergic reaction you experienced, including the symptoms that occurred.
Certain health conditions, including:
+ Respiratory problems, such as asthma, breathing difficulties, or sleep apnea
+ Elevated carbon dioxide levels in the blood
+ Stomach or bowel obstruction or narrowing
Kidney or liver disease
Recent use (within the last 14 days) of specific medications for depression or Parkinson's disease, including isocarboxazid, phenelzine, tranylcypromine, selegiline, or rasagiline, as this may lead to severely high blood pressure
Current use of certain medications, such as buprenorphine, butorphanol, linezolid, methylene blue, nalbuphine, or pentazocine
Presence of mouth sores, which should be discussed with your doctor

This list is not exhaustive, and it is crucial to inform your doctor and pharmacist about all your medications, including prescription and over-the-counter drugs, natural products, and vitamins, as well as any health problems you are experiencing. This will enable them to verify the safety of taking this medication in conjunction with your other medications and health conditions. Do not initiate, discontinue, or modify the dosage of any medication without consulting your doctor.
⚠️

Precautions & Cautions

Important Warnings and Cautions

It is essential to inform all your healthcare providers, including doctors, nurses, pharmacists, and dentists, that you are taking this medication.

Caution with Daily Activities
Avoid driving and engaging in activities that require alertness until you understand how this medication affects you. To minimize the risk of dizziness or fainting, rise slowly from a sitting or lying down position. Be cautious when climbing stairs.

Tolerance and Dependence
Long-term or high-dose use of this medication may lead to tolerance, where the medication becomes less effective, and higher doses may be required to achieve the same effect. If you experience a decrease in the medication's effectiveness, contact your doctor. Do not take more than the prescribed dose.

Additionally, regular use of opioid medications like this one can cause dependence. Suddenly stopping or reducing the dose may increase the risk of withdrawal or other severe problems. Consult your doctor before changing your dose or stopping the medication, and follow their instructions carefully. Monitor for signs of withdrawal, increased pain, mood changes, suicidal thoughts, or other adverse effects, and report them to your doctor.

Safe Use
Do not exceed the prescribed dose, frequency, or duration of treatment, as this may increase the risk of severe side effects. Avoid taking this medication with other strong pain medications or using a pain patch without consulting your doctor first.

If your pain worsens, you become more sensitive to pain, or experience new pain, contact your doctor immediately. Do not take more than the prescribed dose.

Interactions and Contraindications
If you consume grapefruit juice or eat grapefruit regularly, discuss this with your doctor. Do not take this medication with alcohol or products containing alcohol, as this can lead to unsafe and potentially fatal effects.

Seizure Risk
This medication may increase the risk of seizures in some individuals, particularly those with a history of seizures. Consult your doctor to determine if you are at a higher risk of seizures while taking this medication.

Hormonal Effects
Long-term use of opioid medications may lead to decreased sex hormone levels. If you experience a decreased interest in sex, fertility problems, irregular menstrual periods, or ejaculation problems, contact your doctor.

Dental Care
Maintain good oral hygiene and schedule regular dental check-ups.

Diabetes Considerations
If you have high blood sugar (diabetes), consult your doctor, as some products may contain sugar.

Age-Related Precautions
If you are 65 or older, use this medication with caution, as you may be more susceptible to side effects.

Breastfeeding
Inform your doctor if you are breastfeeding, as this medication passes into breast milk and may harm your baby. Seek medical attention immediately if your baby appears overly sleepy, limp, or has breathing difficulties.
πŸ†˜

Overdose Information

Overdose Symptoms:

  • Severe respiratory depression (extremely slow or shallow breathing, cessation of breathing)
  • Profound sedation or coma
  • Pinpoint pupils
  • Cold, clammy skin
  • Limp muscles
  • Bradycardia (slow heart rate)
  • Hypotension (low blood pressure)

What to Do:

IMMEDIATELY call 911 or your local emergency number. Administer naloxone if available and trained to do so. Stay with the person until emergency medical help arrives. Provide rescue breathing if necessary. Call 1-800-222-1222 (Poison Control) for additional guidance.

Drug Interactions

🚫

Contraindicated Interactions

  • Concomitant use with benzodiazepines or other CNS depressants (including alcohol) in patients for whom alternatives are inadequate, due to risk of profound sedation, respiratory depression, coma, and death.
  • Concomitant use with strong CYP3A4 inhibitors (e.g., ritonavir, ketoconazole, itraconazole, clarithromycin, erythromycin, nelfinavir, saquinavir, diltiazem, verapamil, grapefruit juice) due to increased fentanyl plasma concentrations and risk of serious adverse events, including fatal respiratory depression.
  • Patients who are not opioid tolerant.
πŸ”΄

Major Interactions

  • Other CNS depressants (e.g., other opioids, sedatives, hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, phenothiazines, tricyclic antidepressants): Increased risk of respiratory depression, hypotension, profound sedation, coma, and death.
  • Mixed agonist/antagonist opioids (e.g., butorphanol, nalbuphine, pentazocine): May reduce the analgesic effect of fentanyl and/or precipitate withdrawal symptoms.
  • Serotonergic drugs (e.g., SSRIs, SNRIs, TCAs, triptans, mirtazapine, tramadol, linezolid): Risk of serotonin syndrome.
  • CYP3A4 inducers (e.g., rifampin, carbamazepine, phenytoin, St. John's Wort): May decrease fentanyl plasma concentrations, leading to reduced efficacy and potential withdrawal symptoms.
🟑

Moderate Interactions

  • Anticholinergics: Increased risk of urinary retention and/or severe constipation.
  • Diuretics: Opioids may reduce the efficacy of diuretics by causing the release of antidiuretic hormone.
🟒

Minor Interactions

  • Not available

Monitoring

πŸ”¬

Baseline Monitoring

Pain assessment (intensity, characteristics, breakthrough pain episodes)

Rationale: To establish baseline pain levels and determine appropriate dosing for breakthrough pain.

Timing: Prior to initiation and during titration.

Respiratory rate and depth

Rationale: To assess baseline respiratory function and identify risk factors for respiratory depression.

Timing: Prior to initiation.

Level of consciousness/sedation

Rationale: To assess baseline neurological status and identify risk factors for excessive sedation.

Timing: Prior to initiation.

Opioid tolerance status

Rationale: Fentanyl oral transmucosal is only for opioid-tolerant patients. Confirming tolerance is critical for safety.

Timing: Prior to initiation.

πŸ“Š

Routine Monitoring

Pain relief and breakthrough pain episodes

Frequency: Daily or as needed during titration, then regularly during maintenance.

Target: Acceptable pain control with tolerable side effects.

Action Threshold: Inadequate pain relief or excessive side effects warrant dose adjustment or re-evaluation.

Respiratory rate and depth

Frequency: Regularly, especially during titration and after dose changes. Instruct patient/caregiver to monitor.

Target: Normal for patient, typically >10-12 breaths/min.

Action Threshold: Respiratory rate <10 breaths/min, shallow breathing, or signs of hypoventilation (e.g., cyanosis, somnolence) require immediate intervention.

Level of consciousness/sedation

Frequency: Regularly, especially during titration and after dose changes. Instruct patient/caregiver to monitor.

Target: Alert and oriented, able to communicate.

Action Threshold: Excessive sedation (e.g., difficulty arousing, somnolence, confusion) requires intervention.

Bowel function (constipation)

Frequency: Regularly.

Target: Regular bowel movements.

Action Threshold: Constipation requires prophylactic measures (e.g., laxatives) or management.

πŸ‘οΈ

Symptom Monitoring

  • Respiratory depression (slow, shallow breathing, difficulty breathing)
  • Excessive sedation/somnolence
  • Dizziness/lightheadedness
  • Nausea/vomiting
  • Constipation
  • Confusion
  • Miosis (pinpoint pupils)
  • Signs of opioid withdrawal (if abruptly discontinued or dose reduced too quickly)

Special Patient Groups

🀰

Pregnancy

Category C. Use during pregnancy only if the potential benefit justifies the potential risk to the fetus. Prolonged use during pregnancy can result in neonatal opioid withdrawal syndrome, which may be life-threatening if not recognized and treated.

Trimester-Specific Risks:

First Trimester: Potential for increased risk of major congenital malformations, though data for fentanyl specifically is limited and conflicting.
Second Trimester: Risk of neonatal opioid withdrawal syndrome with prolonged use.
Third Trimester: High risk of neonatal opioid withdrawal syndrome with prolonged use. Risk of respiratory depression in the neonate if used close to delivery.
🀱

Lactation

Fentanyl is excreted into breast milk. Due to the potential for serious adverse reactions in breastfed infants (e.g., respiratory depression, sedation), breastfeeding is not recommended during treatment with fentanyl. If breastfeeding cannot be avoided, monitor the infant closely for signs of sedation and respiratory depression.

Infant Risk: High (L5 - Contraindicated/Hazardous)
πŸ‘Ά

Pediatric Use

Safety and effectiveness have not been established in pediatric patients under 16 years of age. Accidental ingestion in children can be fatal. This product is not for use in opioid non-tolerant pediatric patients.

πŸ‘΄

Geriatric Use

Elderly patients may be more sensitive to the effects of fentanyl, particularly respiratory depression. Start with lower doses and titrate slowly. Monitor closely for adverse effects. Consider age-related decreases in renal and hepatic function.

Clinical Information

πŸ’Ž

Clinical Pearls

  • Fentanyl oral transmucosal lozenge is for opioid-tolerant patients only for breakthrough cancer pain. It is NOT for opioid-naive patients or for acute pain management.
  • Strict adherence to the TIRF REMS program is mandatory for prescribing, dispensing, and patient enrollment.
  • Titration is crucial. Patients must be started on the lowest dose (200 mcg) and titrated upwards under medical supervision until an effective dose is found.
  • Instruct patients and caregivers on proper administration (suck, do not chew/swallow), safe storage, and disposal of unused lozenges.
  • Emphasize the risk of accidental exposure, especially to children, and the importance of immediate medical attention if ingested.
  • Warn patients about the dangers of concomitant use with CNS depressants (including alcohol) and CYP3A4 inhibitors.
  • Patients should only use one lozenge per breakthrough pain episode and wait at least 4 hours before treating another episode.
πŸ”„

Alternative Therapies

  • Other short-acting opioids (e.g., immediate-release oxycodone, hydromorphone, morphine) for breakthrough pain (though onset may be slower)
  • Non-opioid analgesics (e.g., NSAIDs, acetaminophen) for mild-moderate pain (not typically sufficient for BTCP)
  • Adjuvant analgesics (e.g., gabapentin, pregabalin, antidepressants) for neuropathic pain components
  • Interventional pain management techniques (e.g., nerve blocks, spinal cord stimulation)
  • Radiation therapy or chemotherapy for underlying cancer pain
πŸ’°

Cost & Coverage

Average Cost: Highly variable, typically several hundred to over a thousand dollars per 30 lozenges
Generic Available: Yes
Insurance Coverage: Tier 3 or 4 (Non-preferred brand/specialty drug). Often requires prior authorization, step therapy, and is subject to quantity limits due to high cost and abuse potential.
πŸ“š

General Drug Facts

If your symptoms or health problems do not improve or worsen over time, it is essential to contact your doctor for further evaluation and guidance. To ensure your safety and the effectiveness of your treatment, never share your medication with others or take someone else's medication.

This medication is accompanied by a Medication Guide, which provides crucial information about its safe use. It is vital to read this guide carefully and review it again whenever your prescription is refilled. If you have any questions or concerns about your medication, do not hesitate to discuss them with your doctor, pharmacist, or other healthcare provider.

In the event of an overdose, a medication called naloxone can be administered to help counteract the effects. Consult with your doctor or pharmacist about obtaining and using naloxone. If you suspect an overdose has occurred, seek immediate medical attention, even if naloxone has been administered. When seeking help, be prepared to provide detailed information about the overdose, including the substance taken, the amount, and the time it occurred.

In case of a suspected overdose, contact your local poison control center or seek emergency medical care right away. Be prepared to provide critical information about the overdose, including the substance taken, the amount, and the time it occurred, to ensure you receive appropriate and timely treatment.